Rozov Yadin
- SEC CIK
- 0001921268
No open-market purchases or sales filed in the past year.
Current role at each company
- DAVE Dave Inc.Directoras of Jun 9, 2026
- CORZ Core Scientific, Inc.Directoras of Feb 6, 2026
- ORMP Oramed Pharmaceuticals Inc.Directoras of Jan 8, 2024
- MDWT Midwest Holding Inc.Directoras of Dec 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rozov Yadin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CORZ Core Scientific, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Rozov YadinDirector | PPurchase | +30.0K | $9.95 | +$298.5K | –30.0K after | Derivative |
| May 29, 2025 (view filing) | May 28 | 1 day | Rozov YadinDirector | PPurchase | +110.0K | $10.87 | +$1.20M | +30.1%475.7K after | |
| Nov 22, 2024 (view filing) | Nov 22 | Same day | Rozov YadinDirector | SSale | −105.0K | $18.11 | −$1.90M | −23.3%345.2K after | |
| May 15, 2024 (view filing) | May 13 | 2 days | Rozov YadinDirector | PPurchase | +105.0K | $2.52 | +$264.6K | –195.0K after | Derivative |
| Mar 18, 2024 (view filing) | Mar 15 | 3 days | Rozov YadinDirector | PPurchase | +80.0K | $3.07 | +$245.6K | New position80.0K after | |
| Mar 18, 2024 (view filing) | Mar 15 | 3 days | Rozov YadinDirector | PPurchase | +90.0K | $2.15 | +$193.5K | –90.0K after | Derivative |
DAVE Dave Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 (view filing) | Sep 12 | Same day | Rozov YadinDirector | SSaleClass A Common Stock | −4.73K | $228.06 | −$1.08M | −5.9%75.2K after | 5 lots10b5-1 |
| Sep 5, 2025 (view filing) | Sep 4 | 1 day | Rozov YadinDirector | SSaleClass A Common Stock | −14.7K | $199.54 | −$2.93M | −15.5%79.9K after | 9 lots10b5-1 |
| Jun 5, 2025 (view filing) | Jun 4 | 1 day | Rozov YadinDirector | SSaleClass A Common Stock | −5.50K | $206.94 | −$1.14M | −5.4%95.7K after | 2 lots |
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | Rozov YadinDirector | PPurchaseClass A Common Stock | +800 | $37.31 | +$29.8K | +0.8%96.5K after | |
| Dec 6, 2023 (view filing) | Dec 4 | 2 days | Rozov YadinDirector | PPurchaseClass A Common Stock | +12.9K | $6.40 | +$82.8K | +15.6%95.7K after |
ORMP Oramed Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 (view filing) | Mar 13-14 | 2 days | Rozov YadinDirector | PPurchase | +70.0K | $2.02 | +$141.7K | +424.2%86.5K after | 2 lots |